FDA Approves Cyberonics' VNS Therapy(TM) System for Treatment-Resistant Depression (TRD) (Medical News
FDA Approves Cyberonics' VNS Therapy(TM) System for Treatment-Resistant Depression (TRD) (Medical News Today)
Cyberonics, Inc. (Nasdaq: CYBX) today announced that the United States Food and Drug Administration (FDA) approved the Vagus Nerve Stimulation (VNS) Therapy System "for the adjunctive long-term treatment of chronic or recurrent depression for patients 18 years of age or older who are experiencing a major depressive episode and have not had an adequate response to four or more adequate
FDA approves implant against depression (Detroit News)
CHICAGO — Cyberonics Inc. received U.S. Food and Drug Administration approval Friday for a pacemaker-like treatment for depression, the first such device.
Beds dedicated to first-time mental health patients (ABC News via Yahoo! Australia & NZ News)
The New South Wales Government has unveiled 20 dedicated mental health hospital beds for first-time sufferers of psychosis, bipolar disorder and depression at Cumberland Hospital in Westmead.
